Blauschmidt et al. (2017) observed that testosterone upregulates the expression of DPP4 receptors in women with polycystic ovary syndrome. DPP4 inhibitors effectively manage COVID-19 through modulation of the anti-inflammatory/pro-inflammatory axis (Mirani et al., 2020). Here, DPP4 is linked to COVID-19.